EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudie

Analysis of systemic opioid prescribing patterns for dyspnea in opioid-naïve cancer patients: a secondary analysis of a multicenter observational study in Japan

Masashi Iida, Masanori Mori, Tomoo Ikari, Kozue Suzuki, Yukako Tanaka-Yagi, Hiroaki Watanabe, Takashi Ohmori, Yoshihisa Matsumoto, Takashi Yamaguchi

Supportive Care in Cancer · 2026

DOI: 10.1007/s00520-025-10264-8 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Supportive Care in Cancer, 2026. Verfasst von Masashi Iida und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Kobe University Hospital, Kobe, Japan. miida@med.kobe-u.ac.jp. Hauptthemen laut MEDLINE: Analgesics, Opioid, Dyspnea, Neoplasms, Practice Patterns, Physicians'. Die Arbeit nennt 18 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Opioids are recommended as first-line pharmacological therapy for cancer dyspnea. However, real-world opioid prescribing practices, including early dose adjustment for patients with impaired organ function, remain unclear. The purpose of this study was to clarify the real-world selection of opioid type and dosage adjustment for cancer-related dyspnea in opioid naïve patients, particularly in those with renal and liver dysfunction. METHODS: A secondary analysis of a multicenter observational study carried out at 12 palliative care facilities across Japan. The subjects were 224 hospitalized adult cancer patients who were opioid naïve and initiated regular systemic opioid therapy for dyspnea. The types of opioids (morphine, oxycodone, hydromorphone, fentanyl) and their dosages (oral morphine equivalent daily dose (OMEDD)) were collected from the initiation (T0) to 72 h later (T3). RESULTS: Morphine was the most frequently selected (132/224, 58.9%), followed by oxycodone (51/224, 22.8%), hydromorphone (30/224, 13.4%), and fentanyl (11/224, 4.9%). Mean OMEDD at T0 and T3 were 15.7 ± 7.7 mg and 20.0 ± 9.7mg for the morphine group, 14.1 ± 4.4 mg and 20.9 ± 10.7mg for oxycodone, 10.9 ± 3.0 mg and 15.8 ± 5.5mg for hydromorphone, and 18.5 ± 5.4 mg and 15.8 ± 7.0mg for fentanyl. In patients with renal dysfunction, oxycodone was the most frequently selected (15/26, 57.7%), and its dosage was increased over time, while the dosage of morphine and fentanyl was stable. In patients with liver dysfunction, morphine was the most frequently selected (12/24, 50.0%), with no significant dosage increases observed for all opioids. CONCLUSION: Morphine was the most frequently selected opioids for dyspnea in patients with cancer. Over the initial 72-h period, opioid dosages increased by 25-50% for most opioids. In patients with renal or liver dysfunction, opioid selection and dosage adjustments reflected clinical considerations of organ function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Analgesics, OpioidDyspneaNeoplasmsPractice Patterns, Physicians'HumansMaleFemaleJapanAgedMiddle AgedMorphineAdultAged, 80 and overPalliative CareOxycodoneDose-Response Relationship, Drug

Stichwörter der Autor:innen

Cancer-related dyspneaObservational studyOpioid naïve patientsPalliative careSystemic opioids

Substanzen

Analgesics, OpioidMorphineOxycodone

Autor:innen und Institutionen

  • Department of Pharmacy, Kobe University Hospital, Kobe, Japan. miida@med.kobe-u.ac.jp.
  • Department of Palliative and Supportive Care, Seirei Mikatahara General Hospital, Hamamatsu, Japan.
  • Department of Palliative Medicine, Tohoku University School of Medicine, Sendai, Japan.
  • Department of Palliative Care, Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Tokyo, Japan.
  • Department of Palliative Care, Konan Medical Center, Hyogo, Japan.
  • Home Palliative Care Asunaro Clinic, Komaki, Japan.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Iida, M., Mori, M., Ikari, T., Suzuki, K., Tanaka-Yagi, Y., Watanabe, H., Ohmori, T., Matsumoto, Y., & Yamaguchi, T. (2026). Analysis of systemic opioid prescribing patterns for dyspnea in opioid-naïve cancer patients: a secondary analysis of a multicenter observational study in Japan. Supportive Care in Cancer. https://doi.org/10.1007/s00520-025-10264-8

Vancouver

Iida M, Mori M, Ikari T, Suzuki K, Tanaka-Yagi Y, Watanabe H, et al. Analysis of systemic opioid prescribing patterns for dyspnea in opioid-naïve cancer patients: a secondary analysis of a multicenter observational study in Japan. Supportive Care in Cancer. 2026. doi:10.1007/s00520-025-10264-8

BibTeX
@article{Iida2026,
  author = {Iida, Masashi and Mori, Masanori and Ikari, Tomoo and Suzuki, Kozue and Tanaka-Yagi, Yukako and Watanabe, Hiroaki and Ohmori, Takashi and Matsumoto, Yoshihisa and Yamaguchi, Takashi},
  title = {Analysis of systemic opioid prescribing patterns for dyspnea in opioid-naïve cancer patients: a secondary analysis of a multicenter observational study in Japan},
  journal = {Supportive Care in Cancer},
  year = {2026},
  doi = {10.1007/s00520-025-10264-8}
}
Kostenlos starten →